Ultralife Corporation
ULBI
$4.13
-$0.15-3.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 164.46M | 165.15M | 168.95M | 168.66M | 158.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 164.46M | 165.15M | 168.95M | 168.66M | 158.64M |
| Cost of Revenue | 122.14M | 122.04M | 124.74M | 125.42M | 119.44M |
| Gross Profit | 42.31M | 43.12M | 44.21M | 43.23M | 39.20M |
| SG&A Expenses | 24.08M | 23.02M | 22.97M | 22.47M | 22.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 154.49M | 152.76M | 155.18M | 155.14M | 149.17M |
| Operating Income | 9.97M | 12.39M | 13.76M | 13.51M | 9.48M |
| Income Before Tax | 8.30M | 10.92M | 12.32M | 13.19M | 9.12M |
| Income Tax Expenses | 1.89M | 1.89M | 2.27M | 2.79M | 1.95M |
| Earnings from Continuing Operations | 6.41 | 9.03 | 10.05 | 10.41 | 7.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -97.00K | -35.00K | 13.00K | 29.00K | 31.00K |
| Net Income | 6.31M | 8.99M | 10.06M | 10.43M | 7.20M |
| EBIT | 9.97M | 12.39M | 13.76M | 13.51M | 9.48M |
| EBITDA | 14.12M | 16.33M | 17.70M | 17.42M | 13.39M |
| EPS Basic | 0.38 | 0.55 | 0.61 | 0.64 | 0.44 |
| Normalized Basic EPS | 0.31 | 0.36 | 0.41 | 0.45 | 0.29 |
| EPS Diluted | 0.38 | 0.54 | 0.60 | 0.63 | 0.43 |
| Normalized Diluted EPS | 0.31 | 0.36 | 0.41 | 0.45 | 0.29 |
| Average Basic Shares Outstanding | 66.22M | 65.93M | 65.54M | 65.11M | 64.85M |
| Average Diluted Shares Outstanding | 66.98M | 66.70M | 66.13M | 65.44M | 65.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |